152 related articles for article (PubMed ID: 19527980)
1. Reproducibility of quantitative optical coherence tomography for stent analysis.
Gonzalo N; Garcia-Garcia HM; Serruys PW; Commissaris KH; Bezerra H; Gobbens P; Costa M; Regar E
EuroIntervention; 2009 Jun; 5(2):224-32. PubMed ID: 19527980
[TBL] [Abstract][Full Text] [Related]
2. Intra- and interobserver reliability and intra-catheter reproducibility using frequency domain optical coherence tomography for the evaluation of morphometric stent parameters and qualitative assessment of stent strut coverage.
Antonsen L; Thayssen P; Junker A; Veien KT; Hansen HS; Hansen KN; Hougaard M; Jensen LO
Cardiovasc Revasc Med; 2015 Dec; 16(8):469-77. PubMed ID: 26475731
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial.
Okamura T; Garg S; Gutiérrez-Chico JL; Shin ES; Onuma Y; García-García HM; Rapoza RJ; Sudhir K; Regar E; Serruys PW
EuroIntervention; 2010 Apr; 5(8):932-8. PubMed ID: 20542778
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining.
Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K
Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265
[TBL] [Abstract][Full Text] [Related]
5. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
8. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
[TBL] [Abstract][Full Text] [Related]
10. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
11. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
[TBL] [Abstract][Full Text] [Related]
12. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
13. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
[TBL] [Abstract][Full Text] [Related]
14. Early coverage of drug-eluting stents analysed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process.
Lee R; Foin N; Ng J; Allen J; Soh N; Ang I; Shim W; Torii R; Wong P
EuroIntervention; 2016 Aug; 12(5):e605-14. PubMed ID: 27497360
[TBL] [Abstract][Full Text] [Related]
15. Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold.
Gómez-Lara J; Brugaletta S; Diletti R; Gogas BD; Farooq V; Onuma Y; Gobbens P; Van Es GA; García-García HM; Serruys PW
Catheter Cardiovasc Interv; 2012 May; 79(6):890-902. PubMed ID: 21523891
[TBL] [Abstract][Full Text] [Related]
16. Strut apposition after coronary stent implantation visualised with optical coherence tomography.
Radu M; Jørgensen E; Kelbaek H; Helqvist S; Skovgaard L; Saunamäki K
EuroIntervention; 2010 May; 6(1):86-93. PubMed ID: 20542802
[TBL] [Abstract][Full Text] [Related]
17. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage.
Barlis P; Dimopoulos K; Tanigawa J; Dzielicka E; Ferrante G; Del Furia F; Di Mario C
Int J Cardiol; 2010 May; 141(2):151-6. PubMed ID: 19155076
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
20. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
